サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1672008

間質血管細胞群の世界市場：産業分析・規模・シェア・成長・動向・予測 (2025-2032年)

Stromal Vascular Fraction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 183 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
間質血管細胞群の世界市場：産業分析・規模・シェア・成長・動向・予測 (2025-2032年)
出版日: 2025年02月26日
発行: Persistence Market Research
ページ情報: 英文 183 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な洞察

  • 間質血管細胞群の市場規模 (2025年)：1億7,290万米ドル
  • 市場規模の予測 (2032年)： 2億7,350万米ドル
  • 世界の市場成長率 (2025～2032年)：CAGR 5.2%

市場成長の促進要因：

世界の間質血管細胞群の市場は、再生療法への需要を刺激する変形性関節症、心血管障害、自己免疫疾患などの慢性疾患の有病率の上昇を含むいくつかの主要な要因によって牽引されています。また、免疫拒絶反応のリスクが低いことから、自己細胞ベースの治療法の採用が増加しており、市場の拡大をさらに後押ししています。酵素フリーや自動処理システムなど、SVF分離手法の技術的進歩も、効率性を高め処理時間を短縮し、SVF療法をより身近なものにしています。さらに、幹細胞研究や再生医療に対する政府支援の増加、バイオテクノロジー企業からの投資の増加も同市場の成長を促進しています。

市場機会：

間質血管細胞群の市場では、新規用途の研究の増加、適応症の拡大、SVF治療と先端バイオテクノロジーとの融合などにより、大きな機会が示されています。神経疾患、創傷治癒、美容医療におけるSVFの潜在的用途は、市場範囲を広げています。さらに、SVF由来細胞を用いた3Dバイオプリンティングや組織工学の進歩も、再生医療に新たな道を開きつつあります。POCでのSVF分離システムの開発や、適正製造規範 (GMP) に準拠したプロトコルの採用も市場拡大の原動力になると予想されています。バイオテクノロジー企業、研究機関、ヘルスケアプロバイダー間の戦略的提携も、技術革新と規制当局の承認を加速させることから、市場の持続的成長を確保するために不可欠です。

当レポートでは、世界の間質血管細胞群の市場を調査し、市場の定義と概要、市場促進要因・抑制要因、各種動向、市場機会、課題、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲・定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

  • 規制状況
  • 製品採用分析
  • バリューチェーン分析
  • 主要な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 世界の間質血管細胞群市場の展望

  • 主なハイライト
  • 市場規模分析と予測
  • 世界の間質血管細胞群市場の展望：製品別
  • 世界の間質血管細胞群市場の展望：用途別
  • 世界の間質血管細胞群市場の展望：エンドユーザー別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析
    • 現在の市場規模の分析・予測
    • 市場の魅力分析

第5章 世界の間質血管細胞群市場の展望：地域別

  • 主なハイライト
  • 過去の市場規模の分析：地域別
  • 現在の市場規模の分析・予測：地域別
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第6章 北米の間質血管細胞群市場の見通し：

第7章 欧州の間質血管細胞群市場の見通し：

第8章 東アジアの間質血管細胞群市場の見通し：

第9章 南アジア・オセアニアの間質血管細胞群市場の見通し：

第10章 ラテンアメリカの間質血管細胞群市場の見通し：

第11章 中東・アフリカ間質血管細胞群市場の見通し：

第12章 競合情勢

  • 市場シェア分析
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Cytori Therapeutics Inc.
    • IntelliCell BioSciences Inc.
    • Cellular Biomedicines Group, Inc.
    • GE Healthcare（Biosafe Group SA）
    • Lifecell Corporation（Allergen PLC）
    • Tissue Genesis Inc.
    • InGeneron, Inc.
    • Human med AG
    • MEDICAN CO., LTD
    • Hairline International
    • Genesis Biosystems, Inc.
    • iXCells Biotechnologies USA, LLC
    • Kyocera Corporation
    • Medikan International Inc.
    • Eurofins Scientific
    • Others

第13章 付録

目次
Product Code: PMRREP20914

Persistence Market Research has recently released a comprehensive report on the worldwide market for stromal vascular fraction (SVF). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stromal vascular fraction market from 2025 to 2032.

Key Insights:

  • Stromal Vascular Fraction Market Size (2025E): US$ 172.9 Million
  • Projected Market Value (2032F):US$ 273.5 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Stromal Vascular Fraction Market - Report Scope:

Stromal vascular fraction (SVF) is a rich source of regenerative cells, including mesenchymal stem cells (MSCs), pericytes, and endothelial cells, derived from adipose tissue. SVF has gained significant attention in regenerative medicine, with applications spanning orthopedics, dermatology, cardiology, and plastic surgery. The increasing demand for minimally invasive therapies, coupled with advancements in stem cell research, is fueling the growth of the SVF market. The market caters to hospitals, specialty clinics, and research institutes, offering a range of SVF isolation systems and enzymatic and non-enzymatic processing techniques.

Market Growth Drivers:

The global stromal vascular fraction market is driven by several key factors, including the rising prevalence of chronic diseases such as osteoarthritis, cardiovascular disorders, and autoimmune conditions, which are fueling the demand for regenerative therapies. The growing adoption of autologous cell-based therapies, due to their lower risk of immune rejection, is further propelling market expansion. Technological advancements in SVF isolation methods, such as enzyme-free and automated processing systems, are enhancing efficiency and reducing processing time, making SVF therapies more accessible. Additionally, increasing government support for stem cell research and regenerative medicine, along with growing investments from biotech companies, is fostering market growth.

Market Restraints:

Despite promising growth prospects, the stromal vascular fraction market faces challenges related to regulatory frameworks, high costs of cell isolation technologies, and ethical concerns surrounding stem cell therapies. Stringent regulatory guidelines governing the clinical use of SVF therapies vary across regions, affecting market adoption and commercial viability. Moreover, the need for specialized equipment and trained personnel increases the overall cost of SVF treatments, limiting their accessibility, particularly in developing economies. Additionally, the lack of long-term clinical data supporting the efficacy and safety of SVF-based treatments poses a challenge for widespread clinical adoption.

Market Opportunities:

The stromal vascular fraction market presents significant opportunities driven by increasing research into novel applications, expanding indications, and the integration of SVF therapies with advanced biotechnologies. The potential use of SVF in neurological disorders, wound healing, and aesthetic medicine is broadening the market scope. Moreover, advancements in 3D bioprinting and tissue engineering using SVF-derived cells are opening new avenues in regenerative medicine. The development of point-of-care SVF isolation systems and the adoption of good manufacturing practice (GMP)-compliant protocols are expected to drive market expansion. Strategic collaborations between biotech firms, research institutions, and healthcare providers are essential to accelerate innovation and regulatory approvals, ensuring sustained market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stromal vascular fraction market globally?
  • Which SVF isolation methods and applications are gaining prominence across different healthcare settings?
  • How are technological advancements shaping the competitive landscape of the SVF market?
  • Who are the key players contributing to the SVF market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global SVF market?

Competitive Intelligence and Business Strategy:

Leading players in the global stromal vascular fraction market, including Cytori Therapeutics, Tissue Genesis, Inc., and InGeneron, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced SVF isolation technologies, including enzyme-free systems, automated processing devices, and closed-loop cell therapy solutions. Collaborations with hospitals, research institutions, and regulatory bodies facilitate market access and promote SVF adoption. Moreover, emphasis on clinical trials, evidence-based research, and patient awareness programs supports the expansion of SVF-based therapies in the regenerative medicine landscape.

Key Companies Profiled:

  • Cytori Therapeutics
  • Tissue Genesis, Inc.
  • InGeneron, Inc.
  • Celltex Therapeutics
  • IntelliCell BioSciences, Inc.
  • LifeCell International Pvt. Ltd.
  • SVF Biosciences
  • Lonza Group
  • PromoCell GmbH
  • RoosterBio, Inc.

Key Segments Covered in Manufacturing of Industry Research

By Product:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products

By Application:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications

By End User:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia and Oceania
  • East Asia
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Stromal Vascular Fraction Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Stromal Vascular Fraction Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Stromal Vascular Fraction Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      • 4.3.3.1. SVF Aspiration Products
      • 4.3.3.2. SVF Transfer Products
      • 4.3.3.3. SVF Isolation Products
        • 4.3.3.3.1. Enzymatic Isolation Products
        • 4.3.3.3.2. Non-enzymatic Isolation Products
        • 4.3.3.3.3. Automated POC Devices
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Stromal Vascular Fraction Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Cosmetic Applications
      • 4.4.3.2. Orthopedic Applications
      • 4.4.3.3. Soft Tissue Applications
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Stromal Vascular Fraction Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Specialty Clinics
      • 4.5.3.3. Stem Cell Banks/Laboratories
      • 4.5.3.4. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Stromal Vascular Fraction Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Stromal Vascular Fraction Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 6.4.1. SVF Aspiration Products
    • 6.4.2. SVF Transfer Products
    • 6.4.3. SVF Isolation Products
      • 6.4.3.1. Enzymatic Isolation Products
      • 6.4.3.2. Non-enzymatic Isolation Products
      • 6.4.3.3. Automated POC Devices
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Cosmetic Applications
    • 6.5.2. Orthopedic Applications
    • 6.5.3. Soft Tissue Applications
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1.
      • 6.6.1.1. Hospitals
      • 6.6.1.2. Specialty Clinics
      • 6.6.1.3. Stem Cell Banks/Laboratories
      • 6.6.1.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Stromal Vascular Fraction Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. SVF Aspiration Products
    • 7.4.2. SVF Transfer Products
    • 7.4.3. SVF Isolation Products
      • 7.4.3.1. Enzymatic Isolation Products
      • 7.4.3.2. Non-enzymatic Isolation Products
      • 7.4.3.3. Automated POC Devices
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Cosmetic Applications
    • 7.5.2. Orthopedic Applications
    • 7.5.3. Soft Tissue Applications
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1.
      • 7.6.1.1. Hospitals
      • 7.6.1.2. Specialty Clinics
      • 7.6.1.3. Stem Cell Banks/Laboratories
      • 7.6.1.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Stromal Vascular Fraction Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. SVF Aspiration Products
    • 8.4.2. SVF Transfer Products
    • 8.4.3. SVF Isolation Products
      • 8.4.3.1. Enzymatic Isolation Products
      • 8.4.3.2. Non-enzymatic Isolation Products
      • 8.4.3.3. Automated POC Devices
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Cosmetic Applications
    • 8.5.2. Orthopedic Applications
    • 8.5.3. Soft Tissue Applications
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1.
      • 8.6.1.1. Hospitals
      • 8.6.1.2. Specialty Clinics
      • 8.6.1.3. Stem Cell Banks/Laboratories
      • 8.6.1.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Stromal Vascular Fraction Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. SVF Aspiration Products
    • 9.4.2. SVF Transfer Products
    • 9.4.3. SVF Isolation Products
      • 9.4.3.1. Enzymatic Isolation Products
      • 9.4.3.2. Non-enzymatic Isolation Products
      • 9.4.3.3. Automated POC Devices
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Cosmetic Applications
    • 9.5.2. Orthopedic Applications
    • 9.5.3. Soft Tissue Applications
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1.
      • 9.6.1.1. Hospitals
      • 9.6.1.2. Specialty Clinics
      • 9.6.1.3. Stem Cell Banks/Laboratories
      • 9.6.1.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Stromal Vascular Fraction Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. SVF Aspiration Products
    • 10.4.2. SVF Transfer Products
    • 10.4.3. SVF Isolation Products
      • 10.4.3.1. Enzymatic Isolation Products
      • 10.4.3.2. Non-enzymatic Isolation Products
      • 10.4.3.3. Automated POC Devices
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Cosmetic Applications
    • 10.5.2. Orthopedic Applications
    • 10.5.3. Soft Tissue Applications
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Stem Cell Banks/Laboratories
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Stromal Vascular Fraction Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. SVF Aspiration Products
    • 11.4.2. SVF Transfer Products
    • 11.4.3. SVF Isolation Products
      • 11.4.3.1. Enzymatic Isolation Products
      • 11.4.3.2. Non-enzymatic Isolation Products
      • 11.4.3.3. Automated POC Devices
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Cosmetic Applications
    • 11.5.2. Orthopedic Applications
    • 11.5.3. Soft Tissue Applications
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Stem Cell Banks/Laboratories
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Cytori Therapeutics Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. IntelliCell BioSciences Inc.
    • 12.3.3. Cellular Biomedicines Group, Inc.
    • 12.3.4. GE Healthcare (Biosafe Group SA)
    • 12.3.5. Lifecell Corporation (Allergen PLC)
    • 12.3.6. Tissue Genesis Inc.
    • 12.3.7. InGeneron, Inc.
    • 12.3.8. Human med AG
    • 12.3.9. MEDICAN CO., LTD
    • 12.3.10. Hairline International
    • 12.3.11. Genesis Biosystems, Inc.
    • 12.3.12. iXCells Biotechnologies USA, LLC
    • 12.3.13. Kyocera Corporation
    • 12.3.14. Medikan International Inc.
    • 12.3.15. Eurofins Scientific
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations